We are closely monitoring any regulation changes from both Boston and Massachusetts with regard to in-person If there are any changes made that will impact our ability to hold the event in-person, we will notify Don't miss the chance to present your innovative research at this year's conference.

discovery and screening applications Understanding GPCR Calcium Assays A GPCR calcium assay measures changes utilize genetically encoded calcium indicators (GECIs), which employ engineered fluorescent proteins that change measurements but typically require additional cell engineering and may exhibit sensitivity to intracellular pH changes Numerous endogenous pathways can contribute to changes in intracellular calcium levels, increasing the studying inverse agonism because constitutive receptor activity does not reliably produce measurable changes

AMA will discuss how these formats diverge, particularly for allosteric ligands, where efficacy can change Allosteric modulators can alter signaling efficacy without changing ligand affinity, uncoupling binding It's the kind of clarity that changes how you read your own data.

These receptors respond to a variety of signals by undergoing structural changes that activate internal brief sequential intervals following GTP addition, the research team identified the conformational changes The captured structures reveal a dynamic of conformational changes initiated by the binding of an agonist This early interaction sets the stage for a cascade of significant conformational changes. Concurrently, the α1 helix extends, propagating structural changes throughout the G protein.

The consequences for assay interpretation are direct: Observed affinity changes reflect altered receptor In contrast, the same curve in an allosteric system reflects a progressive change in receptor affinity implications: Curve shape alone cannot diagnose mechanism Rightward shifts do not imply competition Affinity changes Mechanistically: The allosteric ligand imposes a finite change in affinity (cooperativity constraint)

Kenakin’s latest lecture delivers a game-changing framework for teams grappling with the gap between This lecture is a guide to understanding why intracellular drug access changes everything: from target scaffold permeability using modern, cost-effective pharmacokinetic assays   Why Intracellular GPCR Drugs Change

lanthanide probes, the team realized they could tune these molecules to become exquisitely sensitive to pH changes : Endogenous GLP-1 internalization shown in beta cells 🚀 2025: Revvity launches pHSense A Day That Changed questions about constitutive activity, agonist-induced internalization, and cellular dynamics. 🔄 What Changed

How two-stage GPCR binding creates “high” and “low” affinity states What temporal kinetics quietly change Changing tracer concentration moves the displacement curve. Changing receptor expression or G protein levels does not  remove curve heterogeneity. Non-specific binding control:  Adsorption to surfaces changes free ligand concentration.

In this eye-opening module, Terry Kenakin explores a concept that could change how you interpret pharmacological

. 📚 Whether you're new to pharmacology or brushing up on basics, this lesson will change how you think The receptor may change shape upon binding, affecting how the drug interacts and how effective it will

Allostery and Biased Signaling Change the Game The most profound change in GPCR drug discovery is our discovery teams, pharmacologists refining core skills, and R&D leads who need clear reasoning in a rapidly changing

Mutagenesis involves deliberately altering the DNA sequence of a gene to study the resulting changes framework that combined mutagenesis and structural data to contextualise ligand-induced structural changes datasets, allowing researchers to determine the functional consequences of every possible amino acid change ligand-receptor interactions, mutagenesis fills crucial knowledge gaps by revealing how specific amino acid changes B., Chang, B., & Peisajovich, S. G. (2017).

In environments where the plan changes often, usefulness becomes the multiplier. Usefulness reveals itself only under pressure. ✅ Recognizing this difference changes how founders evaluate It also changes what questions matter when building the team. despite missing information. 2️⃣ How they react to shifting priorities: Ask about situations where plans changed

Allosteric sites operate differently: ligands bind elsewhere, transmit energy changes, and shift the How Conformational Changes Drive Affinity and Efficacy A key takeaway from this session: affinity and That’s where Terry’s Corner changes the game.

neuromodulator, neurotransmitter, etc.), binds to the extracellular binding site of the GPCR, the protein changes the β2 adrenergic receptor (β2AR; PDB ID: 2RH1); (B) A ligand-bound GPCR undergoes a conformational change The conformation change induced by the agonist may not always lead to the same intracellular signaling

That perspective changed the moment he entered GPCR research . That candor changes the tone of collaboration . Pharmacologists know they aren’t being oversold. It also allows Carlsson to stay plugged into the fast-changing needs of biotech while keeping his academic

They start with a chance email, an unexpected visitor at the door, or the moment a team realizes the That changed when JB’s team walked in with a different lens.

is like adjusting the brightness on a microscope—set it right, and hidden details jump into focus, changing Can changing receptor density predict how your drug will behave across sensitive versus less sensitive That’s where Terry’s Corner  changes the game.

extracellular loops and transmembrane domains of the receptor (CRS2), which will trigger conformational changes N-terminal region of chemokine receptors is indispensable for chemokine binding, where the negatively charged residues, as a consequence of the negatively charged aminoacids and post-translational modifications (PTMs), contribute to the high affinity binding to the positively charged groove on the chemokine. N-terminal PTMs include sulfation and glycosylation which contribute to the overall negative charge of

What Changed After This : High-throughput capabilities meant researchers could map GPCR signaling more But the heart of the field hasn’t changed.

“The first time I wore my lucky cactus shirt to a major meeting... and it led to a game-changing collaboration

The date never changed. But the scope moved. If nothing changes after it, it was just a lab update. shared, milestone-driven roadmap tied to strategic decisions, not just scientific deliverables, momentum changes

And until you see it, you can’t change it. What must change? What deserves escalation? ✅ A stable cadence doesn’t eliminate surprise.

Session, You’ll Gain: ✅ A clear explanation of why allosteric modulators don’t displace ligands—they change You’re no longer tracking the same protein species—and that changes everything.

Johannes Broichhagen Reliable imaging tools change how researchers see receptor behavior. specificity, relevance, and assay confidence Read the full HCS feature ➤ Why System-Level GPCR Thinking Changes

There are only 5 spots left for our upcoming courses, so seize the chance to learn from the best in announced the winners of its Transforming Cancer Therapeutics grant, which focuses on developing life-changing

They only feel the consequences months later, when it is hard to change momentum. 👉 This article is Why Results Appear Too Late to Change the Outcome 👉 Most teams focus on results because results feel underlying strategy is sound. 👉 When early strategic decision-making creates alignment, something changes

This week brings sharp new insights into how minor changes in ligand structure can flip GPCR function

announcements in today’s episode, so join us in this celebration and be the first to know about all the changes

But everything changed when his recurring pain — and the rigid protocols around opioid prescription —